Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)


$2.9800
-0.0200 ( -1.06% ) 7.6K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open


$2.9800

Previous close


$3.0000

Volume


7.6K

Market cap


$202.76M

Day range


$3.0100 - $3.1750

52 week range


$2.2800 - $19.0500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 May 31, 2024
4 Insider transactions 1 May 30, 2024
8-k 8K-related 17 May 29, 2024
8-k 8K-related 13 May 20, 2024
10-q Quarterly Reports 75 May 15, 2024
8-k 8K-related 13 May 15, 2024
4 Insider transactions 1 Apr 24, 2024
def Proxies and info statements 5 Apr 18, 2024
8-k 8K-related 12 Apr 16, 2024
8-k 8K-related 12 Apr 08, 2024

Latest News